Science Inventory

Risks to aquatic organisms posed by human pharmaceutical use

Citation:

KOSTICH, M. S. AND J. M. LAZORCHAK. Risks to aquatic organisms posed by human pharmaceutical use. SCIENCE OF THE TOTAL ENVIRONMENT. Elsevier Science Ltd, New York, NY, 389(2-3):329-339, (2008). https://doi.org/10.1016/j.scitotenv.2007.09.008

Impact/Purpose:

For a few active pharmaceutical ingredients, laboratory exposures to environmentally-relevant concentrations have produced effects in non-human species resembling pathology observed in wild populations of similar species.

Description:

In order to help prioritize future research efforts within the US, risks associated with exposure to human prescription pharmaceutical residues in wastewater were estimated from marketing and pharmacological data. Masses of 371 active pharmaceutical ingredients (APIs) dispensed in the US in 2004 were estimated from marketing data, and then divided by therapetuic dose rate to normalize for potency. Metabolic inactivation of the 50 most dispensed APIs was estimated from published data, and active metabolites were tabulated. Comparing maximum likely average wastewater concentrations of API-associated activity to exposure rates that produce therapetuic effects in humans suggests that the threat to healthy human adults from aquatic exposure is low, even when likely mixture effects are considered. Comparing predicted wastewater concentrations to human therapetuic plasma concentrations suggests that some APIs may be present at sufficient concentrations to affect organisms which eliminate them inefficiently. Comparing predicted antimicrobial concentrations to published minimum inhibitory concentrations suggests that antibacterial APIs in wastewater, but probably not antifungal APIs, may select for low-level antimicrobial resistance. The taxonomic distribution of molecular targets of the 50 most dispensed APIs suggests that potential effects of some APIs are likely restricted to vertebrates, while other APIs can probably affect many eukaryotic and prokaryotic clades.

Record Details:

Record Type:DOCUMENT( JOURNAL/ PEER REVIEWED JOURNAL)
Product Published Date:01/25/2008
Record Last Revised:03/19/2019
OMB Category:Other
Record ID: 187108